Huadao Biological won the B round of ¥100 million financing led by NKY

Huadao Biological won the B round of ¥100 million financing led by NKY
Huadao Biological won the B round of ¥100 million financing led by NKY

Huadao Biological completed the B round of ¥100 million financing led by Boai NKY Medical Holdings Ltd. (SZSE:300109). This round of financing will be used for cell drug R&D and cell industrial technological innovation.

In 2017, Huadao Biology focused on drug target research and developed products including leukemia, digestive tract tumors, and other tumors.

South Africa Today


Read more at VolaNews

Disclaimer: The views of authors published on South Africa Today are their own and do not necessarily represent the views of South Africa Today. By viewing, visiting, using, or interacting with SouthAfricaToday.net, you are agreeing to all the provisions of the Terms of Use Policy and the Privacy Policy.